GALR1 and PENK serve as potential biomarkers in invasive non-functional pituitary neuroendocrine tumours

被引:0
|
作者
Wu, Zerui [1 ,2 ]
Rao, Changjun [3 ,4 ]
Xie, Yilin [1 ,2 ]
Ye, Zhen [1 ,2 ]
Zhang, Yichao [1 ,2 ]
Ma, Zengyi [1 ,2 ]
Su, Zhipeng [4 ]
Ye, Zhao [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Ctr Neurol Disorders, Shanghai 200040, Peoples R China
[3] Capital Med Univ, Beijing Neurosurg Inst, Dept Cell Biol, Beijing, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Pituitary tumors; Invasion; GLAR1; PENK; GALANIN RECEPTOR-1; GENE; EXPRESSION; EPIDEMIOLOGY; ADENOMAS;
D O I
10.1016/j.gene.2025.149374
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Some nonfunctioning pituitary neuroendocrine tumor (NFPitNET) can show invasive growth, which increases the difficulty of surgery and indicates a poor prognosis. However, the molecular mechanism related to invasiveness remains to be further studied. This study is to screen and identify the characteristic biomarkers of invasive NFPitNETs. Methods: Based on the data of 73 NFPitNETs microarray chips in the GSE169498 dataset, this study used weighted gene co-expression network (WGCNA), differential expression analysis, protein-protein interaction (PPI) network analysis and various machine learning methods (XGBOOST, LASSO regression, random forest, support vector machine) to screen candidate biomarkers for invasive NFPitNET. Then, using gene set enrichment analysis (GSEA) to explore the differences in biological activities and signaling pathways between invasive NFPitNET and non-invasive NFPitNET. Single-sample GSEA (ssGSEA) was used to analyze key biomarkersrelated signaling pathways. Finally, the expression and function of the key biomarkers were verified by q-RT PCR, immunohistochemical (IHC) experiments and in vitro experiments. Results: Combined with WGCNA and differential expression analysis, 128 high-expression and 85 low-expression candidate biomarkers were preliminarily obtained. PPI analysis and four machine learning algorithms further identified GALR1, PENK and HOXD9. The receiver operating characteristic (ROC) curve results showed that the three biomarkers had good predictive ability of invasiveness. After combining the validation set data, GALR1 and PENK were the final key biomarkers. Finally, PCR and IHC results verified the decreased expression of GALR1 and PENK in invasive NFPitNET and promotes proliferation and invasive ablity of pituitary tumor cells. Conclusion: This study confirmed that the reduced expression of GALR1 and PENK is an important molecular feature of invasive NFPitNETs, which may play an important role in inhibiting the development of NFPitNET.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion
    Tamura, Ryota
    Ohara, Kentaro
    Morimoto, Yukina
    Kosugi, Kenzo
    Oishi, Yumiko
    Sato, Mizuto
    Yoshida, Kazunari
    Toda, Masahiro
    ENDOCRINE PATHOLOGY, 2019, 30 (02) : 81 - 89
  • [22] Exosomal miRNA Profiling is a Potential Screening Route for Non-Functional Pituitary Adenoma
    Lyu, Liang
    Li, Haiyan
    Chen, Cheng
    Yu, Yang
    Wang, Li
    Yin, Senlin
    Hu, Yu
    Jiang, Shu
    Ye, Feng
    Zhou, Peizhi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [23] Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA)
    Heidsma, C. M.
    Engelsman, A. F.
    van Dieren, S.
    Stommel, M. W. J.
    de Hingh, I.
    Vriens, M.
    Hol, L.
    Festen, S.
    Mekenkamp, L.
    Hoogwater, F. J. H.
    Daams, F.
    Klumpen, H-J
    Besselink, M. G.
    van Eijck, C. H.
    van Dijkum, E. J. Nieveen
    BRITISH JOURNAL OF SURGERY, 2021, 108 (08) : 888 - 891
  • [24] Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis
    Misawa, Kiyoshi
    Mochizuki, Daiki
    Endo, Shiori
    Mima, Masato
    Misawa, Yuki
    Imai, Atsushi
    Shinmura, Kazuya
    Kanazawa, Takeharu
    Carey, Thomas E.
    Mineta, Hiroyuki
    MOLECULAR CARCINOGENESIS, 2017, 56 (03) : 1107 - 1116
  • [25] Comment on: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA)
    Wang, Xing
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : E97 - E97
  • [26] Clinical course in MEN1 patients with non-functional pancreatic neuroendocrine tumors
    Brauckhoff, M.
    Hoem, D.
    Havre, R.
    Engebretsen, L.
    Akslen, L.
    Husebye, E.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S149 - S149
  • [27] Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients
    Cheng, Tingting
    Wang, Ya
    Lu, Miaolong
    Zhan, Xianquan
    Zhou, Tian
    Li, Biao
    Zhan, Xianquan
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [28] Recurrence and outcomes of non-functional pancreatic neuroendocrine tumours post-resection: an Australian retrospective, multicentre cohort study
    Lim, Sean
    Chong, Lynn
    Peeroo, Saania
    Onasanya, Olukunle
    He, Evelyn
    Banting, Simon
    Croagh, Daniel
    ANZ JOURNAL OF SURGERY, 2023, 93 (1-2) : 160 - 165
  • [29] Author response to: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: Nationwide prospective cohort study (PANDORA)
    Heidsma, C. M.
    Nieveen van Dijkum, E. J.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : E98 - E98
  • [30] Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: Case report and literature review
    Sinnott B.P.
    Hatipoglu B.
    Sarne D.H.
    Pituitary, 2006, 9 (1) : 65 - 72